- Home
- SKYH vs RNAC Comparison
SKYH vs RNAC Comparison
Compare SKYH & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKYH
- RNAC
- Stock Information
- Founded
- SKYH 2017
- RNAC 2007
- Country
- SKYH United States
- RNAC United States
- Employees
- SKYH N/A
- RNAC N/A
- Industry
- SKYH Military/Government/Technical
- RNAC Biotechnology: Pharmaceutical Preparations
- Sector
- SKYH Industrials
- RNAC Health Care
- Exchange
- SKYH Nasdaq
- RNAC Nasdaq
- Market Cap
- SKYH 344.5M
- RNAC 276.3M
- IPO Year
- SKYH N/A
- RNAC 2016
- Fundamental
- Price
- SKYH $9.88
- RNAC $8.17
- Analyst Decision
- SKYH Strong Buy
- RNAC Strong Buy
- Analyst Count
- SKYH 3
- RNAC 4
- Target Price
- SKYH $13.83
- RNAC $40.00
- AVG Volume (30 Days)
- SKYH 92.3K
- RNAC 142.6K
- Earning Date
- SKYH 11-07-2025
- RNAC 11-07-2025
- Dividend Yield
- SKYH N/A
- RNAC N/A
- EPS Growth
- SKYH N/A
- RNAC N/A
- EPS
- SKYH N/A
- RNAC N/A
- Revenue
- SKYH $20,919,000.00
- RNAC $1,026,000.00
- Revenue This Year
- SKYH $118.09
- RNAC N/A
- Revenue Next Year
- SKYH $88.34
- RNAC N/A
- P/E Ratio
- SKYH N/A
- RNAC N/A
- Revenue Growth
- SKYH 94.38
- RNAC N/A
- 52 Week Low
- SKYH $9.28
- RNAC $7.75
- 52 Week High
- SKYH $14.52
- RNAC $26.50
- Technical
- Relative Strength Index (RSI)
- SKYH 45.05
- RNAC 34.87
- Support Level
- SKYH $9.77
- RNAC $7.91
- Resistance Level
- SKYH $10.60
- RNAC $9.49
- Average True Range (ATR)
- SKYH 0.37
- RNAC 0.58
- MACD
- SKYH -0.03
- RNAC -0.11
- Stochastic Oscillator
- SKYH 14.29
- RNAC 11.53
About SKYH Sky Harbour Group Corporation
Sky Harbour Group Corp is an aviation infrastructure company building a nationwide network of Home-based solutions for business aircraft. The company develops, leases, and manages business aviation hangars across the United States based on its proprietary targeting and acquisition model, targeting airfields with hangar supply and demand imbalances in the markets. Its hangar campuses feature exclusive private hangars and a full suite of dedicated services specifically designed for home-based aircraft.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.